QS Investors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-7,145
Closed -$172K 1635
2019
Q2
$172K Sell
7,145
-2,300
-24% -$67.8K ﹤0.01% 1255
2019
Q1
$351K Sell
9,445
-112,664
-92% -$4.1M ﹤0.01% 1074
2018
Q4
$3.45M Buy
122,109
+8,299
+7% +$263K 0.04% 336
2018
Q3
$4.49M Sell
113,810
-21,898
-16% -$958K 0.04% 314
2018
Q2
$6.02M Buy
135,708
+1,504
+1% +$74.8K 0.06% 229
2018
Q1
$6.54M Sell
134,204
-6,391
-5% -$319K 0.07% 189
2017
Q4
$7.04M Buy
140,595
+2,542
+2% +$133K 0.07% 198
2017
Q3
$6.99M Sell
138,053
-2,122
-2% -$100K 0.06% 213
2017
Q2
$5.32M Buy
140,175
+17,317
+14% +$683K 0.05% 286
2017
Q1
$4.73M Buy
+122,858
New +$3.7M 0.04% 315
2016
Q3
Sell
-29
Closed -$1K 1939
2016
Q2
$1K Buy
+29
New +$258 ﹤0.01% 1566

Other funds holding CC

QS Investors's CC Position: Q3 2019 in Review

QS Investors sold out of Chemours (CC) in Q3 2019, closing a stake of 7,145 shares — an estimated $172K sold.

QS Investors first reported a position in CC in Q2 2016 and held it in 11 quarters. The position peaked at $7.04M in Q4 2017. 418 funds tracked by Wall St. Rank hold CC as of Q3 2019.

  • QS Investors reported no remaining Chemours position as of Q3 2019 after selling out during the quarter.
  • QS Investors sold 7,145 Chemours shares in Q3 2019, an estimated $172K.
  • QS Investors first reported a position in Chemours in Q2 2016 and held it in 11 quarters.
  • QS Investors's Chemours position peaked at $7.04M in Q4 2017.
  • 418 funds tracked by Wall St. Rank held Chemours as of Q3 2019.

Based on QS Investors's 13F filing for Q3 2019, filed 14 Nov 2019.